Liver Research Group
The Liver Research group at Indiana University School of Medicine strongly believes that clinical research is vital to advance the understanding and treatment for various liver disorders. For instance, through clinical research, investigators gain insights and answers about the safety and effectiveness of drugs and other treatment interventions. Groundbreaking scientific advances in the present and the past were possible only because of active voluntary participation of patients and their families.
Faculty investigators focused on liver research help patients overcome barriers that prevent patients from taking part in clinical trials. These barriers may include lack of awareness, fear of side effects, assignment to placebo arm, confusion about insurance coverage and lastly time commitment and travel time to the research facility. Despite these barriers, the research program has had tremendous success over the years with recruitment and retention due to motivated patients who want to have access to new treatments and help advance science.
Breakthroughs in the field of liver disease have led to new treatment options for liver disorders. These agents are currently under study through various phases of drug development. Completion of two (rarely one) studies with positive results is often required prior to approval by regulatory authorities.
Details about IU School of Medicine clinical trials focused on diabetes are available through the school’s Center for Diabetes and Metabolic Diseases.